User profiles for "author:Mandeep R. Mehra"

Mandeep R. Mehra, MBBS, MSc, FRCP

Brigham and Women's Hospital and Harvard Medical School
Verified email at bwh.harvard.edu
Cited by 64182

[HTML][HTML] Extrapulmonary manifestations of COVID-19

A Gupta, MV Madhavan, K Sehgal, N Nair… - Nature medicine, 2020 - nature.com
Although COVID-19 is most well known for causing substantial respiratory pathology, it can
also result in several extrapulmonary manifestations. These conditions include thrombotic …

Omega-3 polyunsaturated fatty acids and cardiovascular diseases

CJ Lavie, RV Milani, MR Mehra, HO Ventura - Journal of the American …, 2009 - jacc.org
Omega-3 polyunsaturated fatty acid (ω-3 PUFA) therapy continues to show great promise in
primary and, particularly in secondary prevention of cardiovascular (CV) diseases. The most …

Impact of obesity and the obesity paradox on prevalence and prognosis in heart failure

CJ Lavie, MA Alpert, R Arena, MR Mehra, RV Milani… - JACC: Heart Failure, 2013 - jacc.org
Obesity has reached epidemic proportions in the United States and worldwide. Considering
the adverse effects of obesity on left ventricular (LV) structure, diastolic and systolic function …

Endothelial cell infection and endotheliitis in COVID-19

Z Varga, AJ Flammer, P Steiger, M Haberecker… - The Lancet, 2020 - thelancet.com
Cardiovascular complications are rapidly emerging as a key threat in coronavirus disease
2019 (COVID-19) in addition to respiratory disease. The mechanisms underlying the …

COVID-19 illness in native and immunosuppressed states: A clinical–therapeutic staging proposal

HK Siddiqi, MR Mehra - The journal of heart and lung transplantation, 2020 - jhltonline.org
The onslaught of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)‒
associated disease that developed in 2019, COVID-19, has gripped the world in a pandemic …

[HTML][HTML] Cardiovascular disease, drug therapy, and mortality in Covid-19

MR Mehra, SS Desai, SR Kuy, TD Henry… - New England Journal …, 2020 - Mass Medical Soc
Abstract Background Coronavirus disease 2019 (Covid-19) may disproportionately affect
people with cardiovascular disease. Concern has been aroused regarding a potential …

Retraction—Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis

MR Mehra, F Ruschitzka, AN Patel - The lancet, 2020 - thelancet.com
several concerns were raised with respect to the veracity of the data and analyses
conducted by Surgisphere Corporation and its founder and our co-author, Sapan Desai, in …

The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: a 10-year update

MR Mehra, CE Canter, MM Hannan… - The Journal of Heart …, 2016 - jhltonline.org
In 2005, the International Society for Heart and Lung Transplantation (ISHLT) Board of
Directors commissioned the development of the first International Listing Criteria for Heart …

Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates—2006

MR Mehra, J Kobashigawa, R Starling… - The Journal of heart …, 2006 - jhltonline.org
Two of the previous International Society for Heart and Lung Transplantation (ISHLT)
consensus conferences have addressed listing criteria for patients awaiting heart …

[HTML][HTML] A fully magnetically levitated left ventricular assist device

MR Mehra, N Uriel, Y Naka… - … England Journal of …, 2019 - Mass Medical Soc
Background In two interim analyses of this trial, patients with advanced heart failure who
were treated with a fully magnetically levitated centrifugal-flow left ventricular assist device …